๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Whitby
Clinical trial register · Canada

Clinical Trials in Whitby, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 6540 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:55 UTC
6540
Studies in scope
all four open statuses
3515
Recruiting now
open to new participants
887
Lead sponsors
across recruiting studies
Top sites
Toronto 2809 Montreal 1902 Vancouver 1179 Calgary 1061 Edmonton 1017
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Whitby

19 of 6540 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Recruiting
A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)
NCT06947941Alzheimer Disease, Psychosis
Bristol-Myers Squibb
Phase 3
325
Toronto, Whitby, Montreal
2026-03-25
Recruiting
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
NCT07284472Agitation Associated With Alzheimer's Disease Dementia
Exciva GmbH
Phase 2/3
300
North York, Peterborough, Whitby
2026-02-02
Recruiting
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
NCT06937229Alzheimer Disease, Agitation
Bristol-Myers Squibb
Phase 3
650
Hamilton, London, Toronto, Whitby
2025-12-02
Active, closed
A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome
NCT07211685Alport Syndrome
Bayer
Phase 2
60
Hamilton, London, Whitby, Montreal, Quรฉbec
2025-11-19
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
NCT07011732Alzheimer Disease
Bristol-Myers Squibb
Phase 3
426
Hamilton, London, Toronto, Whitby, Montreal
2025-07-10
Recruiting
Predictors of Relapse in Major Depressive Disorder (PERFORM-D)
NCT06746155Major Depressive Disorder (MDD)
Abraham Nunes
Observational
252
Calgary, Vancouver, Halifax, Hamilton, Kingston, Ottawa, Toronto, Whitby
2024-12-27
Active, closed
Effect of Retatrutide Compared With Semaglutide in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)
NCT06260722Diabetes Mellitus, Type 2
Eli Lilly and Company
Phase 3
1,250
Calgary, Edmonton, Brampton, Hamilton, Sarnia, Toronto, Whitby, Montreal
2024-02-21
Recruiting
An Innovative Master Platform for Clinical Trials in Mood Disorders
NCT06408012Mood Disorders, Depressive Disorder, Bipolar and Related Disorders
St. Joseph's Healthcare Hamilton
Observational
2,200
Calgary, Vancouver, Halifax, Hamilton, Kingston, Ottawa, Toronto, Whitby
2023-10-17
Recruiting
Cannabidiol Medication Intervention Trial
NCT06014424Alzheimer Disease
Sunnybrook Health Sciences Centre
Phase 2
40
Calgary, London, Toronto, Whitby
2023-09-27
Recruiting
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
NCT06126224Psychosis Associated With Alzheimer's Disease
DrugKarXT
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
500
Calgary, Hamilton, Toronto, Whitby, Montreal, Verdun
2023-08-28
Recruiting
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
NCT05980949Psychosis Associated With Alzheimer's Disease
DrugKarXT
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
1,000
Calgary, Hamilton, Whitby, Montreal, Verdun
2023-07-11
Recruiting
Type 1 Diabetes Virtual Self-management Education and Support
NCT05756829type1diabetes
Unity Health Toronto
Not applicable
580
Kitchener, Richmond Hill, Toronto, Whitby
2023-05-10
Recruiting
Outcomes From Remediation and Behavioural Intervention Techniques
NCT05731414Schizophrenia, Psychosis, Psychotic Disorders, Schizophrenia; Psychosis
University of Toronto
Not applicable
360
Scarborough Village, Whitby
2023-03-01
Recruiting
Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
NCT05017311Major Depressive Disorder
Nova Scotia Health Authority
Phase 4
400
Calgary, Vancouver, Halifax, Hamilton, Kingston, Ottawa, Toronto, Whitby
2023-01-20
Active, closed
Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
NCT05172726Plaque Psoriasis
Organon and Co
Phase 3
58
Calgary, Edmonton, St. John's, Markham, Waterloo, Whitby, Montreal
2021-12-02
Recruiting
Predictors of Mental Health in Men With Prostate Cancer Undergoing a Patient Empowerment Program
NCT04895839Prostate Cancer
Gabriela Ilie
Not applicable
2,130
Edmonton, Kelowna, Winnipeg, Saint John, St. John's, Halifax, Toronto, Whitby
2021-09-29
Recruiting
Nabilone for Agitation Blinded Intervention Trial
NCT04516057Alzheimer Disease, Agitation
Sunnybrook Health Sciences Centre
Phase 3
112
Calgary, London, Toronto, Whitby
2021-02-01
Active, closed
Standardizing Care for Neuropsychiatric Symptoms and Quality of Life in Dementia
NCT03672201Alzheimer's Disease, Alzheimer Dementia (AD), Aggression
Centre for Addiction and Mental Health
Not applicable
187
Calgary, Kingston, London, Toronto, Whitby, Montreal
2018-11-01
Active, closed
Escitalopram for Agitation in Alzheimer's Disease
NCT03108846Dementia
JHSPH Center for Clinical Trials
Phase 3
187
Calgary, London, Toronto, Whitby
2018-01-03
Rows per page Showing 1–19 of 19
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-canada/city/whitby

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,540 studies in total at the last sync on 26 Sep 2026, 19:55 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 19 of those studies with a site in Whitby.

How many clinical trials are recruiting in Whitby?

14 of the 19 studies on this page are recruiting new participants as of the 26 Sep 2026, 19:55 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Whitby), 19 studies
PhaseStudiesRecruitingShare
Phase 39647.4%
Not applicable4321.1%
Observational2210.5%
Phase 22110.5%
Phase 2/3115.3%
Phase 4115.3%

Most active sponsors

Lead sponsors with the most studies (Whitby)
Lead sponsorStudiesRecruiting
Bristol-Myers Squibb33
Karuna Therapeutics, Inc., a Bristol Myers Squibb company22
Sunnybrook Health Sciences Centre22
Abraham Nunes11
Bayer10
Centre for Addiction and Mental Health10
Eli Lilly and Company10
Exciva GmbH11
Gabriela Ilie11
JHSPH Center for Clinical Trials10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.